Literature DB >> 11114315

Familial aggregation of Parkinson's disease in Iceland.

S Sveinbjörnsdottir1, A A Hicks, T Jonsson, H Pétursson, G Guğmundsson, M L Frigge, A Kong, J R Gulcher, K Stefansson.   

Abstract

BACKGROUND: The role of genetics in early-onset Parkinson's disease has been established, but whether there is a genetic contribution to the more common, late-onset form remains uncertain.
METHODS: We reviewed the medical records and confirmed the diagnosis of Parkinson's disease in 772 living and deceased patients in whom the disease had been diagnosed during the previous 50 years in Iceland. With the use of an extensive computerized data base containing genealogic information on 610,920 people in Iceland during the past 11 centuries, several analyses were conducted to determine whether the patients were more related to each other than random members of the population (control subjects).
RESULTS: Patients with Parkinson's disease, including a subgroup of 560 patients with late-onset disease (onset at >50 years of age), were significantly more related to each other than were subjects in matched groups of controls, and this relatedness extended beyond the nuclear family. The risk ratio for Parkinson's disease was 6.7 (95 percent confidence interval, 4.3 to 9.6) for siblings, 3.2 (95 percent confidence interval, 1.2 to 7.8) for offspring, and 2.7 (95 percent confidence interval, 1.6 to 3.9) for nephews and nieces of patients with late-onset Parkinson's disease.
CONCLUSIONS: Late-onset Parkinson's disease has a genetic component as well as an environmental component.

Entities:  

Mesh:

Year:  2000        PMID: 11114315     DOI: 10.1056/NEJM200012143432404

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  52 in total

Review 1.  Rare genetic mutations shed light on the pathogenesis of Parkinson disease.

Authors:  Ted M Dawson; Valina L Dawson
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 2.  Current concepts in the diagnosis and management of Parkinson's disease.

Authors:  Mark Guttman; Stephen J Kish; Yoshiaki Furukawa
Journal:  CMAJ       Date:  2003-02-04       Impact factor: 8.262

Review 3.  The genetic basis of Parkinson's disease.

Authors:  T Foltynie; S Sawcer; C Brayne; R A Barker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

Review 4.  Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2012-07-07       Impact factor: 5.996

5.  Familial risks of hospitalization for Parkinson's disease in first-degree relatives: a nationwide follow-up study from Sweden.

Authors:  Kristina Sundquist; Xinjun Li; Kari Hemminki
Journal:  Neurogenetics       Date:  2006-08-30       Impact factor: 2.660

Review 6.  The application of NMR-based metabonomics in neurological disorders.

Authors:  Elaine Holmes; Tsz M Tsang; Sarah J Tabrizi
Journal:  NeuroRx       Date:  2006-07

7.  The advantages of dense marker sets for linkage analysis with very large families.

Authors:  Russell Thomson; Stephen Quinn; James McKay; Jeremy Silver; Melanie Bahlo; Liesel FitzGerald; Simon Foote; Jo Dickinson; Jim Stankovich
Journal:  Hum Genet       Date:  2007-01-25       Impact factor: 4.132

8.  Knowledge and attitudes towards genetic testing in those affected with Parkinson's disease.

Authors:  Tracey M Scuffham; Aideen McInerny-Leo; Shu-Kay Ng; George Mellick
Journal:  J Community Genet       Date:  2013-09-10

Review 9.  Epidemiology of Parkinson's disease.

Authors:  Ole-Bjørn Tysnes; Anette Storstein
Journal:  J Neural Transm (Vienna)       Date:  2017-02-01       Impact factor: 3.575

10.  A heritable predisposition to pituitary tumors.

Authors:  William T Couldwell; Lisa Cannon-Albright
Journal:  Pituitary       Date:  2010-06       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.